Use of carbenicillin in patients with cystic fibrosis.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001219:Aspartate Aminotransferases / Q000097:blood; D001555:Benzene Derivatives / Q000008:administration & dosage; D003550:Cystic Fibrosis / Q000150:complications*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D010406:Penicillins / Q000008:administration & dosage*; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D001555:Benzene Derivatives; D005839:Gentamicins; D010406:Penicillins; D001219:Aspartate Aminotransferases